AtriCure (ATRC) Stock: Buy, Sell, or Hold?
ATRC - AtriCure, Inc.
$53.31
-0.29 (-0.53%)
âŧ
5d:
-8.69%
30d:
+1.36%
90d:
+64.57%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When ATRC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ATRC is fairly priced but lacks strong directional signals. At 9.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ATRC is fairly priced but lacks strong directional signals. At 9.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.02
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRC is currently trading at $53.30, which is considered fair relative to its 30-day fair value range of $50.31 to $58.32. From a valuation perspective, the stock is trading at a premium (Forward PE: 124.1) compared to its historical average (93.5). At these levels, the market is pricing in 9.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ATRC is in a strong uptrend. The price is currently testing key support at $52.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ATRC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATRC is in a strong uptrend. The price is currently testing key support at $52.60. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ATRC scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$50.31 -
$58.32
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.3%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($53.33)
- NEUTRAL: Trading at premium valuation - market expects 9.9% growth which is achievable
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$50.31 -
$58.32
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$52.60
Resistance Level
$61.70
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
124.11
Wall Street Target
$53.33
(-0.5%)
Revenue Growth (YoY)
12.8%
Profit Margin
1.8%
Valuation Premium vs History
+9.9% premium
PE vs Historical
124.1 vs 93.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.9%
(market-implied from PE analysis)
1-Year Target
$58.90
(+10%)
2-Year Target
$64.73
(+21%)
3-Year Target
$71.13
(+33%)
3-Yr Target (if PE normalizes)
(PE: 124â94)
PE COMPRESSION
$53.59
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 124.1, Growth: 51.9%)
$180.87
(+238%)
Base:
(SPY PE: 20.4, Growth: 51.9%)
$29.73
(-45%)
Bear:
(PE: 17.3, Growth: 51.9%)
$25.27
(-53%)
Share & Embed Analysis
Last updated: October 02, 2026 10:40 AM ET
Data refreshes hourly during market hours. Next update: 11:40 AM
Data refreshes hourly during market hours. Next update: 11:40 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 50 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 33 SELL |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 58 HOLD |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$408 | 52 HOLD |
